An Overview of Antibiotic Therapy for Early- and Late-Onset Neonatal Sepsis: Current Strategies and Future Prospects
Neonatal sepsis is a clinical syndrome mainly associated with a bacterial infection leading to severe clinical manifestations that could be associated with fatal sequalae. According to the time of onset, neonatal sepsis is categorized as early- (EOS) or late-onset sepsis (LOS). Despite blood culture...
Main Authors: | Giovanni Boscarino, Rossana Romano, Carlotta Iotti, Francesca Tegoni, Serafina Perrone, Susanna Esposito |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-03-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/13/3/250 |
Similar Items
-
Biomarkers of Neonatal Sepsis: Where We Are and Where We Are Going
by: Giovanni Boscarino, et al.
Published: (2023-07-01) -
Risk Factors Associated with Early and Late-onset of Neonatal Sepsis in Duhok City
by: Delshad Abdallah Mohamed, et al.
Published: (2020-05-01) -
Trends and spatial distribution of neonatal sepsis, Uganda, 2016–2020
by: Stella M. Migamba, et al.
Published: (2023-11-01) -
Late-onset neonatal sepsis in Arab states in the Gulf region: two-year prospective study
by: Majeda S. Hammoud, et al.
Published: (2017-02-01) -
Soluble CD14 subtype (sCD14-ST) as biomarker in neonatal early-onset sepsis and late-onset sepsis: a systematic review and meta-analysis
by: Iris van Maldeghem, et al.
Published: (2019-06-01)